Not yet recruiting
Phase II Interventional Study Evaluating Efficacy and Safety of Secukinumab in Active Severe Takayasu Patients
NCT07477795
- Conditions
- Aortic Arch Syndromes, Aortic Diseases, Arteritis, +8 more
- Locations
-
Not specified